McKinsey Advised Johnson & Johnson on Increasing Opioid Sales
In a trial in Oklahoma, records showed the firm was consulted about sales at a time when abuse of pain medicine was widespread. Cases in two other states also shed light on its role.
Source: NYT Health - Category: Consumer Health News Authors: Walt Bogdanich Tags: Opioids and Opiates Drugs (Pharmaceuticals) Fentanyl Duragesic (Drug) OxyContin (Drug) Advertising and Marketing McKinsey & Johnson Janssen Pharmaceutica Purdue Pharma Teva Pharmaceutical Industries Ltd Balkman, Thad Oklahoma N Source Type: news
More News: Advertising | Fentanyl | Health | Marketing | Oxycodone | OxyContin | Pain | Pharmaceuticals | Substance Abuse